3644 results for «2954»
3644 results
Imaging to the rescue in LAA closure
20 May 2026 – From EuroPCR 2026
This session highlights the pivotal role of advanced imaging modalities in left atrial appendage (LAA) closure. Topics include novel risk assessment workflows for air embolism, evaluation protocols using cardiac CT and 3D TEE, reproducibility of anatomical classifications, and long-term follow-up outcomes with various imaging techniques.
Intracoronary imaging to guided DCB PCI
20 May 2026 – From EuroPCR 2026
This session highlights the role of intracoronary imaging techniques such as OCT and IVUS in guiding drug-coated balloon (DCB) PCI. It explores novel imaging-guided algorithms for complex bifurcations, prediction of drug-eluting balloon failure, management of calcified nodules, re-entry into true lumen during CTO, and tackling aneurysms...
Navigating the complexity of high bleeding risk
20 May 2026 – From EuroPCR 2026
Focusing on patients with high bleeding risk undergoing PCI, this session presents contemporary evidence on prevalence, procedural strategies with different stent types, antiplatelet therapy considerations including diabetic and sex-specific outcomes, and novel technologies such as sirolimus-coated balloons and machine learning models for restenosis prediction.
Choosing the right strategy for isolated ostial left anterior descending artery or circumflex coronary lesions
20 May 2026 – From EuroPCR 2026
This session examines optimal strategies for managing isolated ostial lesions in the left anterior descending and circumflex arteries, comparing left main crossover, ostial stenting, and drug-coated balloon (DCB) approaches. It emphasizes integrating multimodality imaging for informed decision-making, illustrated through detailed case discussions.
Best complications on calcified lesions
20 May 2026 – From EuroPCR 2026
Highlighting challenging cases in calcified coronary lesions, this session presents a series of complications including stuck wires, the Kokeshi phenomenon, and multiple complications within a single vessel. It provides practical insights into rescue techniques and navigating complex procedural challenges.
How to obtain a surgical-liked result in a patient with primary mitral regurgitation?
20 May 2026 – From EuroPCR 2026
This session delves into achieving surgical-like outcomes in patients with primary mitral regurgitation undergoing transcatheter edge-to-edge repair (TEER). It covers anatomical criteria for optimal patient selection, essential procedural steps including device choice and imaging guidance, and key factors contributing to durable success and patient improvement.
Typical chest pain: atypical angiogram
20 May 2026 – From EuroPCR 2026
This session addresses the management challenges posed by acute coronary syndromes when angiographic findings are ambiguous or atypical. It highlights the role of intravascular imaging in clarifying diagnoses and discusses recent insights from clinical cases and key studies such as DISCO and the latest NSTEMI EuroIntervention...
Registries and trials in TMVR
20 May 2026 – From EuroPCR 2026
This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.
When the angiogram shows no answer for your AMI patient: what's next?
20 May 2026 – From EuroPCR 2026
This session focuses on non-occlusive causes of acute coronary syndromes (ACS) when angiograms do not reveal clear pathology. It emphasizes the diagnostic value of intracoronary imaging for conditions such as MINOCA and spontaneous coronary artery dissection (SCAD), and discusses optimal treatment strategies and prognostic considerations.
Prognostics elements on multivessel disease and coronary artery disease
20 May 2026 – From EuroPCR 2026
This session examines key prognostic elements in multivessel and coronary artery disease, featuring studies on mechanical circulatory support across LDL-C levels, biomarkers impacting periprocedural myocardial infarction, autologous cell therapy outcomes for refractory angina, and novel risk stratification indices. It also addresses prognosis in cancer patients and...
Stentless PCI, DCB and BVS in complex scenarios
20 May 2026 – From EuroPCR 2026
This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.
DCB - Going beyond in-stent restenosis
20 May 2026 – From EuroPCR 2026
This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.
New tools for risk stratification in STEMI
20 May 2026 – From EuroPCR 2026
This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.
Management of rare clinical scenarios in the cathlab
20 May 2026 – From EuroPCR 2026
This session addresses the management of rare and complex clinical scenarios encountered in the catheterization laboratory. Cases include dyspnea in coronary artery bypass graft patients, aortocoronary dissection management, complications during coronary sinus reducer implantation, coronary artery aneurysms related to IgG4 vasculitis, ibuprofen-induced Kounis syndrome, and challenging...
Complications in coronary interventions
20 May 2026 – From EuroPCR 2026
This session reviews uncommon and challenging complications encountered during coronary interventions. Cases include brachial arteriovenous fistula following radial access, retained guidewires, coronary sinus perforation during device implantation, and complex atherectomy procedures, emphasizing preparedness and management strategies.
Combination of dedicated devices for optimal treatment of calcified lesions
20 May 2026 – From EuroPCR 2026
Focused on the optimal treatment of heavily calcified coronary lesions, this session presents a comprehensive overview of dedicated device combinations. It highlights strategies such as rotablation, rotatripsy, and approaches to managing protruding calcified nodules and undilatable lesions, emphasizing a stepwise approach to complex calcium modification in...
Reliability and application of angio-based physiology in daily work
20 May 2026 – From EuroPCR 2026
This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.
First-in-human studies in cardiovascular devices: from first 10 patients to global innovation — How efficient early studies advance emerging technologies
20 May 2026 – From EuroPCR 2026
Understand the pivotal role of first-in-human studies in advancing cardiovascular device innovation through operational insights from early patient experiences. This session reviews cutting-edge technologies including percutaneous left ventricular assist devices, transcatheter leaflet augmentation, physiology-guided PCI, synchronized diaphragmatic stimulation, pulmonary artery denervation, and perspectives on translating early...
TAV-in-SAV TAVI procedure - LIVE case
21 May 2026 – From EuroPCR 2026
A 70‑year‑old man with COPD and a history of severe aortic stenosis treated with SAVR (27 mm Perimount Magna) in 2012, followed by endocarditis in 2013, presented with symptomatic degeneration of the surgical valve, predominantly as severe aortic regurgitation. Left ventricular function was preserved (LVEF 50%)...
Adopting a step-by-step approach for successful redo TAVI
21 May 2026 – From EuroPCR 2026
This session outlines a systematic step-by-step approach for redo TAVI procedures, including detailed pre-procedural CT analysis. It addresses challenges associated with failing short and tall-frame valves, and discusses coronary protection and leaflet modification techniques critical for successful reinterventions.
